Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Days Payable : 789.60 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals Days Payable?

Clinuvel Pharmaceuticals's average Accounts Payable for the six months ended in Dec. 2023 was $3.11 Mil. Clinuvel Pharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2023 was $0.72 Mil. Hence, Clinuvel Pharmaceuticals's Days Payable for the six months ended in Dec. 2023 was 789.60.

The historical rank and industry rank for Clinuvel Pharmaceuticals's Days Payable or its related term are showing as below:

CLVLF' s Days Payable Range Over the Past 10 Years
Min: 20.28 Med: 40.72 Max: 208.45
Current: 208.45

During the past 13 years, Clinuvel Pharmaceuticals's highest Days Payable was 208.45. The lowest was 20.28. And the median was 40.72.

CLVLF's Days Payable is ranked better than
59.38% of 714 companies
in the Biotechnology industry
Industry Median: 147.95 vs CLVLF: 208.45

Clinuvel Pharmaceuticals's Days Payable increased from Dec. 2022 (211.51) to Dec. 2023 (789.60). It may suggest that Clinuvel Pharmaceuticals delayed paying its suppliers.

Clinuvel Pharmaceuticals Days Payable Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Days Payable Chart

Clinuvel Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

52.16

55.72

139.77

48.52

63.62

Clinuvel Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															139.82	58.23	211.51	94.61	789.60

Competitive Comparison of Clinuvel Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinuvel Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's Days Payable falls into.

Clinuvel Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Clinuvel Pharmaceuticals's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (0.182	+	1.874)	/	2 )	/	5.898	*	365
=	1.028					/	5.898	*	365
=	63.62

Clinuvel Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (1.874	+	4.339)	/	2 )	/	0.718	*	365 / 2
=	3.1065					/	0.718	*	365 / 2
=	789.60

Clinuvel Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CLVLY:USA UR9:Germany CUV:Australia

Address

535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000

Website

https://www.clinuvel.com

Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.